Contact Us
UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
September 18, 2026 6 min read

Summary and Key Takeaways from FDA’s September 2026 Public Hearing on Psychedelic Drugs
On September 14, 2026, FDA convened a Part 15 hearing to discuss "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs." The meeting was a compilation of 2 minute segments for 80 public commentators representing a diverse community of academia, patients, advocates, service providers, and industry.
Rachel Bonfanti, MPH
Executive Director, Risk Management & Scientific Consulting
Featured Image
Blog
September 15, 2026 11 min read

The Physician Layer: Why Medical Oversight in PV is Non-Negotiable
Yes, automation can process volume. What it can't do is exercise clinical judgment on a case that doesn't fit the pattern, defend a causality assessment to a health authority inspector, or carry a program's institutional history from one reviewer to the next. Those are not workflow steps. They're physician functions.
Alexis Pinçon, MD
Director, Global Medical Services & Medical Writing
Featured Image
Blog
September 1, 2026 17 min read

Best Practices in Oncology Joint Clinical Assessment (JCA) Submissions Under the EU HTA Regulation
The first oncology JCA reports show that this new EU assessment process is anything but routine. Here's what sponsors can learn from early submissions, and how to prepare for what's ahead.

Posts by Date

Two women walk across a large, modern lobby with dark marble floors, flanked by wooden slatted walls and stairs.
Blog
December 4, 2024 7 min read

Driving Program Awareness through Stakeholder Collaboration
This article explores strategies to enhance Patient Service Programs (PSPs) awareness through digital engagement and provider collaboration.
A man with glasses and a beard sits on a couch, looking down at a laptop in front of him. He is wearing a light-colored shirt.
Blog
November 11, 2024 4 min read

Standardization and the Evolving REMS Landscape
Learn about the FDA's new guidance, the challenges of standardization, and how UBC is driving innovation in REMS implementation using modern APIs from UBC's VP of Data Intelligence and Program Analytics, Jim Shamp.
A person with an IV in their arm uses a smartphone while sitting in a chair, focusing on the technology.
Blog
November 1, 2024 4 min read

The Evolution of Patient Support for Cell and Gene Therapy Products
Discover UBC's insights from the Cell & Gene Meeting on the Mesa, the unique challenges patients face, and the importance of tailored support services to ensure successful treatment journeys
A person in white gloves loads blood sample tubes with yellow caps and barcodes into a laboratory machine for analysis.
Blog
October 23, 2024 7 min read

The impact of CKD: Why better, accessible treatments and diagnostics are crucial
Supporting National Kidney Week 2024
A young man at home on a call with his patient services case manager
Blog
October 14, 2024 1 min read

Podcast | Boosting Patient Adherence: The Power of Clinical Support Programs
UBC talked to Pharmaceutical Commerce about what artificial intelligence capabilities could do to impact patient access in 2024 and beyond.
Four business professionals in suits, two women and two men, are shaking hands and smiling in a modern office setting.
Blog
October 14, 2024 5 min read

The Importance of Good Collaboration between Different Vendors to Ensure Compliance with Global and Local Regulations
In the realm of pharmaceuticals, regulatory compliance is paramount to ensure patient safety. With the complex environment of safety reporting, several vendors may be involved at global and local levels for performing submission activities to health authorities, ethics committees and investigators. Director of UBC Global Case Processing, Myrto Ioannidi and UBC Team Manager, Esther Aparicio review […]
Two clinical researchers brainstorming in a modern office
Blog
October 1, 2024 4 min read

DCTs: Beyond Hype and To a Hybrid Future
Clinical trials provide a limited view of patient experience but this can be expanded through tokenization to link pre- and post-trial data.
A network of blue human figures connected by dashed lines, with one red figure prominently in the center, symbolizing a central connection.
Blog
September 16, 2024 5 min read

The Importance of Choosing the Right Pharmacovigilance Partner and Safety Physician
For most pharmaceutical companies, hiring a PV team will help alleviate some of the work of the existing internal team.
Middle-aged female therapists sits with a patient on the couch and comforts him, putting him at ease.
Blog
August 29, 2024 6 min read

Putting the ‘Patient’ Back in Patient Services
Putting the patient back in patient services means we do more, go deeper, and customize offerings.
1 … 5 6 7 8 9 … 21

Press Inquires

UBC logo white

Thank You for Connecting with UBC

.

 

What You Can Expect Next

.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.